Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Login and Edit functionaility are currrently unavailable.
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin.
Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration.
A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity.
Desialylation accelerates platelet clearance after refrigeration and initiates GPIba metalloproteinase-mediated cleavage in mice.
Congenital Disorders of Glycosylation
Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect.
Biosynthesis and Function of Lactosaminyl Glycans in Hematopoiesis
Molecular Analysis of CD44 on Colon Cancer Cells
Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells.
A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.
mRNA-mediated glycoengineering ameliorates deficient homing of human stem cell-derived hematopoietic progenitors.
Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications.
Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis
Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding.
The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation.